Form 4: Jaguar Health CEO Lisa Conte Reports Stock Unit Conversion
SEC Form 4 Filing
Lisa Conte, CEO of Jaguar Health, reports the conversion of restricted stock units into common stock.
Summary
- On May 17, 2024, Lisa Conte, CEO and President of Jaguar Health, converted 2,695 restricted stock units into common stock.
- Following the transaction, Conte directly owns 7,295 shares of common stock and 2,694 restricted stock units.
- The restricted stock units vest in three equal annual installments beginning on May 17, 2023.
- The restricted stock units were originally approved on March 28, 2022, and adjusted to reflect a 75-for-1 reverse stock split on January 23, 2023.
Sentiment
Score: 5
Explanation: This is a neutral filing regarding stock unit conversion, with no inherent positive or negative implications.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company executives.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it primarily reflects an internal conversion of equity.
Key Dates
| Date | Description |
|---|---|
| March 28, 2022 | Restricted stock units originally approved by the issuer's board of directors. |
| January 23, 2023 | 75-for-1 reverse stock split of Jaguar Health's common stock. |
| May 17, 2023 | First vesting date for the restricted stock units. |
| May 17, 2024 | Date of the reported transaction: conversion of restricted stock units into common stock. |
| May 21, 2024 | Date of signature for the Form 4 filing. |
Keywords
Jaguar Health, Lisa Conte, Stock Units, Common Stock, Form 4, SEC Filing, Reverse Stock Split, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.